Absolute binding free energy calculations of sparsomycin analogs to the bacterial ribosome
- PMID: 20608691
- DOI: 10.1021/jp100579y
Absolute binding free energy calculations of sparsomycin analogs to the bacterial ribosome
Abstract
The interactions of the 50S subunit of bacterial ribosome with antibiotic sparsomycin (SPS) and five analogs (AN) are investigated through the calculation of the standard (absolute) binding free energy and the characterization of conformational dynamics. The standard binding free energies of the complexes are computed using free energy perturbation molecular dynamics (FEP/MD) simulations with explicit solvent. Restraining potentials are applied and then released during the simulation to efficiently sample the changes in translational, orientational, and conformational freedom of the ligand and receptor upon binding. The biasing effects of the restraining potentials are rigorously removed. The loss of conformational freedom of the ligand upon binding is determined by introducing a potential of mean force (PMF) as a function of the root-mean-square deviation (rmsd) of the ligand relative to its conformation in the bound state. To reduce the size of the simulated system, the binding pocket of the ribosome is simulated in the framework of the generalized solvent boundary potential (GSBP). The number of solvent molecules in the buried binding site is treated via grand canonical Monte Carlo (GCMC) during the FEP/MD simulations. The correlation coefficient between the calculated and measured binding free energies is 0.96, and the experimentally observed ranking order for the binding affinities of the six ligands is reproduced. However, while the calculated affinities of the strong binders agree well with the experimental values, those for the weak binders are underestimated.
Similar articles
-
Calculation of the standard binding free energy of sparsomycin to the ribosomal peptidyl-transferase P-site using molecular dynamics simulations with restraining potentials.J Mol Recognit. 2010 Mar-Apr;23(2):128-41. doi: 10.1002/jmr.996. J Mol Recognit. 2010. PMID: 20151411
-
Computation of binding free energy with molecular dynamics and grand canonical Monte Carlo simulations.J Chem Phys. 2008 Mar 21;128(11):115103. doi: 10.1063/1.2842080. J Chem Phys. 2008. PMID: 18361618
-
Absolute binding free energy calculations using molecular dynamics simulations with restraining potentials.Biophys J. 2006 Oct 15;91(8):2798-814. doi: 10.1529/biophysj.106.084301. Epub 2006 Jul 14. Biophys J. 2006. PMID: 16844742 Free PMC article.
-
Molecular recognition of RNA: challenges for modelling interactions and plasticity.J Mol Recognit. 2010 Mar-Apr;23(2):220-31. doi: 10.1002/jmr.1000. J Mol Recognit. 2010. PMID: 19941322 Review.
-
Computations of standard binding free energies with molecular dynamics simulations.J Phys Chem B. 2009 Feb 26;113(8):2234-46. doi: 10.1021/jp807701h. J Phys Chem B. 2009. PMID: 19146384 Free PMC article. Review.
Cited by
-
CHARMM-GUI Ligand Binder for absolute binding free energy calculations and its application.J Chem Inf Model. 2013 Jan 28;53(1):267-77. doi: 10.1021/ci300505n. Epub 2012 Dec 20. J Chem Inf Model. 2013. PMID: 23205773 Free PMC article.
-
Absolute Binding Free Energies between T4 Lysozyme and 141 Small Molecules: Calculations Based on Multiple Rigid Receptor Configurations.J Chem Theory Comput. 2017 Jun 13;13(6):2930-2944. doi: 10.1021/acs.jctc.6b01183. Epub 2017 May 1. J Chem Theory Comput. 2017. PMID: 28430432 Free PMC article.
-
Computational analysis of the binding specificity of Gleevec to Abl, c-Kit, Lck, and c-Src tyrosine kinases.J Am Chem Soc. 2013 Oct 2;135(39):14741-53. doi: 10.1021/ja405939x. Epub 2013 Sep 20. J Am Chem Soc. 2013. PMID: 24001034 Free PMC article.
-
Ligand-dependent conformations and dynamics of the serotonin 5-HT(2A) receptor determine its activation and membrane-driven oligomerization properties.PLoS Comput Biol. 2012;8(4):e1002473. doi: 10.1371/journal.pcbi.1002473. Epub 2012 Apr 19. PLoS Comput Biol. 2012. PMID: 22532793 Free PMC article.
-
Explaining why Gleevec is a specific and potent inhibitor of Abl kinase.Proc Natl Acad Sci U S A. 2013 Jan 29;110(5):1664-9. doi: 10.1073/pnas.1214330110. Epub 2013 Jan 14. Proc Natl Acad Sci U S A. 2013. PMID: 23319661 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources